insights_auto
Hvorfor har MBIO gått ned? 6,69%?
Gå mer i dybdenchevron_right
MBIO:NASDAQ
Mustang Bio Inc
0,42 USD
arrow_downward
−6,69%(−0,030) 1 D
8. okt., 16:00:00 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for MBIO …
Åpne
0,45 USD
Høy
0,45 USD
Lav
0,41 USD
Markedsverdi
3,11 mill.
Snittvolum
26,25k
Volum
0,00
52 u høy
1,84 USD
52 u lav
0,41 USD
EPS
−0,46 USD
Beta
2,09
Utestående aksjer
6,73 mill.
Antall ansatte
4
Åpne
0,45 USD
Høy
0,45 USD
Lav
0,41 USD
Markedsverdi
3,11 mill.
Snittvolum
26,25k
Volum
0,00
52 u høy
1,84 USD
52 u lav
0,41 USD
EPS
−0,46 USD
Beta
2,09
Utestående aksjer
6,73 mill.
Antall ansatte
4
Nyhetssaker
Fra nettkilder og nyhetspartnere
https://www.dars.gov.et/
·
for 1 måned siden
Mustang (MBIO) Financial Results: The Bottom-Line Figure Trails Its Comparison; Post-Earnings: Shares Finish 1.11% Lower at the Close - Earnings Growth Forecast
Profil
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
Om Mustang Bio Inc
Administrerende direktørManuel Litchman
Ansatte4
Grunnlagt2015
HovedkontorWaltham, Massachusetts, USA
Sektor-
Nettstedmustangbio.com